The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - RadioMedix
Consulting or Advisory Role - Endocyte; Ipsen
Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings.
 
Ida Sonni
No Relationships to Disclose
 
Matthias Eiber
Consulting or Advisory Role - ABX Advanced biochemical compounds; Blue Earth Diagnostics
Research Funding - ABX Advanced biochemical compounds; Blue Earth Diagnostics; Siemens
Patents, Royalties, Other Intellectual Property - patent application for rhPSMA
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Wolfgang Fendler
No Relationships to Disclose
 
Rejah M. Alano
No Relationships to Disclose
 
Sitaram S. Vangala
No Relationships to Disclose
 
Amar Upadhyaya Kishan
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Janssen
 
Nicholas George Nickols
Stock and Other Ownership Interests - Gene Sciences
Consulting or Advisory Role - Gene Sciences; Gene Sciences; PRogenics; PRogenics
Research Funding - Janssen Scientific Affairs; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences
 
Matthew Rettig
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Genomic Health; ImaginAb; Janssen Oncology
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Johannes Czernin
Leadership - SOFIE; Trethera
Consulting or Advisory Role - Actinium Pharmaceuticals
Research Funding - Johnson Comprehensive Cancer Center National Institutes of Health-National Cancer Institute Cancer Center Support Grant (Inst); Prostate Cancer Foundation (Inst); United States Department of Energy (Inst)
 
Jeremie Calais
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Clovis Oncology; Endocyte; Progenics
Honoraria - Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics